EUVIMEDEUVIMED entdecken
Historischer BeitragÜbersichtsarbeitOpen Access · CC BY 4.0

Thalidomide‐induced teratogenesis: History and mechanisms

Neil Vargesson

Birth Defects Research Part C: Embryo Today: Reviews · 2015-06 · 105 (2) · 140-156

DOI: 10.1002/bdrc.21096 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Birth Defects Research Part C: Embryo Today: Reviews, online erschienen am 04.06.2015. Verfasst von Neil Vargesson. Beteiligte Einrichtung: School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom. Die Arbeit wurde bisher 851-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nearly 60 years ago thalidomide was prescribed to treat morning sickness in pregnant women. What followed was the biggest man‐made medical disaster ever, where over 10,000 children were born with a range of severe and debilitating malformations. Despite this, the drug is now used successfully to treat a range of adult conditions, including multiple myeloma and complications of leprosy. Tragically, a new generation of thalidomide damaged children has been identified in Brazil. Yet, how thalidomide caused its devastating effects in the forming embryo remains unclear. However, studies in the past few years have greatly enhanced our understanding of the molecular mechanisms the drug. This review will look at the history of the drug, and the range and type of damage the drug caused, and outline the mechanisms of action the drug uses including recent molecular advances and new findings. Some of the remaining challenges facing thalidomide biologists are also discussed. Birth Defects Research (Part C) 105:140–156, 2015. © 2015 The Authors Birth Defects Research Part C: Embryo Today: Reviews Published by Wiley Periodicals, Inc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abnormalities, Drug-InducedAdultAnimalsFemaleHistory, 20th CenturyHistory, 21st CenturyHumansMalePregnancyTeratogenesisTeratogensThalidomide

Stichwörter der Autor:innen

Fgf8Shhactin cytoskeletonangiogenesiscell deathcereblonlimb developmentphocomeliareactive oxygen speciesvascular transition

Substanzen

TeratogensThalidomide

Autor:innen und Institutionen

  • School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom.

Förderung

  • Wellcome Trust

Zitieren

APA

Vargesson, N. (2015). Thalidomide‐induced teratogenesis: History and mechanisms. Birth Defects Research Part C: Embryo Today: Reviews, 105(2), 140-156. https://doi.org/10.1002/bdrc.21096

Vancouver

Vargesson N. Thalidomide‐induced teratogenesis: History and mechanisms. Birth Defects Research Part C: Embryo Today: Reviews. 2015;105(2):140-156. doi:10.1002/bdrc.21096

BibTeX
@article{Vargesson2015,
  author = {Vargesson, Neil},
  title = {Thalidomide‐induced teratogenesis: History and mechanisms},
  journal = {Birth Defects Research Part C: Embryo Today: Reviews},
  year = {2015},
  volume = {105},
  number = {2},
  pages = {140--156},
  doi = {10.1002/bdrc.21096}
}
Kostenlos starten →